Lv72
5000 积分 2022-03-23 加入
Expanding Conjugate Space of RNAi Therapeutics: Ligand at the 3′ End of the Antisense Strand Achieves Uncompromised In Vivo Potency and Efficacy and Reveals Interactions with the Argonaute-2 PAZ Domain
16天前
已完结
Preclinical Pharmacology of Angiotensin II Receptor AntagonistsUpdate and Outstanding Issues
6个月前
已关闭
Application of allometry principles for the prediction of human pharmacokinetic parameters for irbesartan, a AT1 receptor antagonist, from animal data
6个月前
已完结
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells
8个月前
已完结
Observations from a decade of oligonucleotide bioanalysis by LC-MS
8个月前
已完结
Frameworks for transformational breakthroughs in RNA-based medicines
9个月前
已完结
Pharmacokinetics and Tissue Distribution of a Peptide Nucleic Acid After Intravenous Administration
1年前
已完结
5′‐(E)‐Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA–GalNAc Conjugates
1年前
已完结
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
1年前
已完结
Considerations for Creating the Next Generation of RNA Therapeutics: Oligonucleotide Chemistry and Innate Immune Responses to Nucleic Acids
1年前
已完结
皖公网安备34019202002308
